Download PDF
CC BY-NC-ND 4.0 · Asian J Neurosurg 2025; 20(01): 112-118
DOI: 10.1055/s-0044-1796663
Original Article

Factors Predicting Recurrence and Resolution of Chronic SDH after Surgery

Shashin N. Vyas 
1   Department of Neurosurgery, Sawai Man Singh Hospital, Jaipur, Rajasthan, India
,
Achal Sharma
1   Department of Neurosurgery, Sawai Man Singh Hospital, Jaipur, Rajasthan, India
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Background Chronic subdural hematoma (SDH) is notoriously known to have high recurrence rates after surgery. We followed the course of 100 postoperative patients to determine the various stipulated factors associated with recurrence.

Materials and Methods In our study of 100 patients, there was a significant association with the size of SDH, amount of midline shift, increasing age, less duration of primary injury, and the increasing incidence of delayed resolution and recurrence. Also, the membrane of the patients with recurrent SDH was found to have a collection of neutrophils, plasma cells, histiocytes, and lymphocytes.

Conclusion Large size of SDH, increasing age, and recent injury were significant determining factors for delayed resolution and recurrence.

Keywords

intracranial - subdural - recurrence - chronic - case series

Authors' Contributions

S.N.V. collected the data and wrote the manuscript and A.S. did the proofreading and advised on corrections.




Publication History

Article published online:
13 January 2025

© 2025. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Kolias AG, Chari A, Santarius T, Hutchinson PJ. Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol 2014; 10 (10) 570-578
    CrossrefPubMedSearch in Google Scholar
  • 2 Asghar M, Adhiyaman V, Greenway MW, Bhowmick BK, Bates A. Chronic subdural haematoma in the elderly: a North Wales experience. J R Soc Med 2002; 95 (06) 290-292
    PubMedSearch in Google Scholar
  • 3 Cousseau DH, Echevarría Martín G, Gaspari M, Gonorazky SE. Chronic and subacute subdural haematoma. An epidemiological study in a captive population. Rev Neurol 2001; 32 (09) 821-824
    PubMedSearch in Google Scholar
  • 4 Kudo H, Kuwamura K, Izawa I, Sawa H, Tamaki N. Chronic subdural hematoma in elderly people: present status on Awaji Island and epidemiological prospect. Neurol Med Chir (Tokyo) 1992; 32 (04) 207-209
    CrossrefPubMedSearch in Google Scholar
  • 5 Santarius T, Kirkpatrick PJ, Ganesan D. et al. Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial. Lancet 2009; 374 (9695) 1067-1073
    CrossrefPubMedSearch in Google Scholar
  • 6 Ducruet AF, Grobelny BT, Zacharia BE. et al. The surgical management of chronic subdural hematoma. Neurosurg Rev 2012; 35 (02) 155-169 , discussion 169
    CrossrefPubMedSearch in Google Scholar
  • 7 Ridwan S, Bohrer AM, Grote A, Simon M. Surgical treatment of chronic subdural hematoma: predicting recurrence and cure. World Neurosurg 2019; 128: e1010-e1023
    CrossrefPubMedSearch in Google Scholar
  • 8 Nakaguchi H, Tanishima T, Yoshimasu N. Factors in the natural history of chronic subdural hematomas that influence their postoperative recurrence. J Neurosurg 2001; 95 (02) 256-262
    CrossrefPubMedSearch in Google Scholar
  • 9 Yamamoto H, Hirashima Y, Hamada H, Hayashi N, Origasa H, Endo S. Independent predictors of recurrence of chronic subdural hematoma: results of multivariate analysis performed using a logistic regression model. J Neurosurg 2003; 98 (06) 1217-1221
    CrossrefPubMedSearch in Google Scholar
  • 10 Ramachandran R, Hegde T. Chronic subdural hematomas: causes of morbidity and mortality. Surg Neurol 2007; 67 (04) 367-372 , discussion 372–373
    CrossrefPubMedSearch in Google Scholar
  • 11 Stanišic M, Pripp AH. A reliable grading system for prediction of chronic subdural hematoma recurrence requiring reoperation after initial burr-hole surgery. Neurosurgery 2017; 81 (05) 752-760
    CrossrefPubMedSearch in Google Scholar
  • 12 Nanko N, Tanikawa M, Mase M. et al. Involvement of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in the mechanism of development of chronic subdural hematoma. Neurol Med Chir (Tokyo) 2009; 49 (09) 379-385
    CrossrefPubMedSearch in Google Scholar
  • 13 Hua C, Zhao G, Feng Y, Yuan H, Song H, Bie L. Role of matrix metalloproteinase-2, matrix metalloproteinase-9, and vascular endothelial growth factor in the development of chronic subdural hematoma. J Neurotrauma 2016; 33 (01) 65-70
    CrossrefPubMedSearch in Google Scholar
  • 14 Hong HJ, Kim YJ, Yi HJ, Ko Y, Oh SJ, Kim JM. Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma. Surg Neurol 2009; 71 (02) 161-165 , discussion 165–166
    CrossrefPubMedSearch in Google Scholar
  • 15 Frati A, Salvati M, Mainiero F. et al. Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J Neurosurg 2004; 100 (01) 24-32
    CrossrefPubMedSearch in Google Scholar
  • 16 Markwalder TM. Chronic subdural hematomas: a review. J Neurosurg 1981; 54 (05) 637-645
    CrossrefPubMedSearch in Google Scholar
  • 17 Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 2017; 14 (01) 108
    CrossrefPubMedSearch in Google Scholar
  • 18 Gelabert-González M, Iglesias-Pais M, García-Allut A, Martínez-Rumbo R. Chronic subdural haematoma: surgical treatment and outcome in 1000 cases. Clin Neurol Neurosurg 2005; 107 (03) 223-229
    CrossrefPubMedSearch in Google Scholar
  • 19 Nomura S, Kashiwagi S, Fujisawa H, Ito H, Nakamura K. Characterization of local hyperfibrinolysis in chronic subdural hematomas by SDS-PAGE and immunoblot. J Neurosurg 1994; 81 (06) 910-913
    CrossrefPubMedSearch in Google Scholar
  • 20 Sarkar C, Lakhtakia R, Gill SS, Sharma MC, Mahapatra AK, Mehta VS. Chronic subdural haematoma and the enigmatic eosinophil. Acta Neurochir (Wien) 2002; 144 (10) 983-988 , discussion 988
    CrossrefPubMedSearch in Google Scholar
  • 21 Osuka K, Watanabe Y, Usuda N, Aoyama M, Takeuchi M, Takayasu M. Eotaxin-3 activates the Smad pathway through the transforming growth factor beta 1 in chronic subdural hematoma outer membranes. J Neurotrauma 2014; 31 (16) 1451-1456
    CrossrefPubMedSearch in Google Scholar
  • 22 Varricchi G, Galdiero MR, Loffredo S. et al. Eosinophils: the unsung heroes in cancer?. OncoImmunology 2017; 7 (02) e1393134
    CrossrefPubMedSearch in Google Scholar
  • 23 Rosenberg HF, Dyer KD, Foster PS. Eosinophils: changing perspectives in health and disease. Nat Rev Immunol 2013; 13 (01) 9-22
    CrossrefPubMedSearch in Google Scholar
  • 24 Murakami H, Hirose Y, Sagoh M. et al. Why do chronic subdural hematomas continue to grow slowly and not coagulate? Role of thrombomodulin in the mechanism. J Neurosurg 2002; 96 (05) 877-884
    CrossrefPubMedSearch in Google Scholar
  • 25 Rohde V, Graf G, Hassler W. Complications of burr-hole craniostomy and closed-system drainage for chronic subdural hematomas: a retrospective analysis of 376 patients. Neurosurg Rev 2002; 25 (1-2): 89-94
    CrossrefPubMedSearch in Google Scholar
  • 26 Torihashi K, Sadamasa N, Yoshida K, Narumi O, Chin M, Yamagata S. Independent predictors for recurrence of chronic subdural hematoma: a review of 343 consecutive surgical cases. Neurosurgery 2008; 63 (06) 1125-1129 , discussion 1129
    CrossrefPubMedSearch in Google Scholar
  • 27 Lee KS. Natural history of chronic subdural haematoma. Brain Inj 2004; 18 (04) 351-358
    CrossrefPubMedSearch in Google Scholar
  • 28 Delgado-López PD, Martín-Velasco V, Castilla-Díez JM, Rodríguez-Salazar A, Galacho-Harriero AM, Fernández-Arconada O. Dexamethasone treatment in chronic subdural haematoma. Neurocirugia (Astur) 2009; 20 (04) 346-359
    CrossrefPubMedSearch in Google Scholar
  • 29 Mori K, Maeda M. Surgical treatment of chronic subdural hematoma in 500 consecutive cases: clinical characteristics, surgical outcome, complications, and recurrence rate. Neurol Med Chir (Tokyo) 2001; 41 (08) 371-381
    CrossrefPubMedSearch in Google Scholar
  • 30 Matsumoto K, Akagi K, Abekura M. et al. Recurrence factors for chronic subdural hematomas after burr-hole craniostomy and closed system drainage. Neurol Res 1999; 21 (03) 277-280
    CrossrefPubMedSearch in Google Scholar
  • 31 Amirjamshidi A, Abouzari M, Eftekhar B. et al. Outcomes and recurrence rates in chronic subdural haematoma. Br J Neurosurg 2007; 21 (03) 272-275
    CrossrefPubMedSearch in Google Scholar
  • 32 Fogelholm R, Heiskanen O, Waltimo O. Chronic subdural hematoma in adults. Influence of patient's age on symptoms, signs, and thickness of hematoma. J Neurosurg 1975; 42 (01) 43-46
    CrossrefPubMedSearch in Google Scholar
  • 33 Abouzari M, Rashidi A, Rezaii J. et al. The role of postoperative patient posture in the recurrence of traumatic chronic subdural hematoma after burr-hole surgery. Neurosurgery 2007; 61 (04) 794-797 , discussion 797
    CrossrefPubMedSearch in Google Scholar